Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.99	-223.91	266.52
Graham Fair Price	35.91	5.95	4.37
PEG	-85.21	-0.20	1.33
Price/Book	-2.88	2.10	2.16
Price/Cash Flow	-67.56	-61.61	189.94
Prices/Earnings	49.57	-17.93	-35.56
Price/Sales	-5.16	12.42	13.10
Price/FCF	-67.56	-61.61	189.94
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-8.65	0.40	0.43
Operating Margin	-50.99	-0.18	-0.12
ROA	-93.60	-0.02	< 0.005
ROE	-0.02	-0.03	-92.60
ROIC	-0.01	-0.02	-67.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-42.11
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.23	-0.52	122.36
EPS QOQ	0.27	-0.91	240.91
FCF QOQ	2.10	-3.94	87.65
Revenue QOQ	0.02	< 0.005	-81.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	24.72	19.41	-21.47
Days Sales Outstanding (DSO)	75.93	81.86	7.82
Inventory Turnover	3.64	4.64	27.34
Debt/Capitalization	0.39	0.37	-5.93
Quick Ratio	5.67	6.87	21.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.48	7.32	-2.07
Cash	3.30	3.05	-7.45
Capex	-0.06	-0.04	20.97
Free Cash Flow	0.09	-0.25	193.23
Revenue	1.24	1.24	0.30
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.20	7.48	20.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	31.10	-27.90	-10.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating